In addition, in human breast cancer cells, STAT6 functions in G1/S cell cycle progression, and the growth-inhibitory effects of STAT6 are mediated by induction of the G1 CDK inhibitors p21Cip1/WAF1 (p21) and p27Kip1 (p27)25. Here, CDKN1A is linked to breast cancer.